ARCHIVES

NLST Suggests 18.5 Percent Of LDCT-Detected Cancers Could Be Indolent

This article is from The Cancer Letter archive.

Vol. 36 No. 12 | December 27, 2013

Download PDF Visit The Full Archive

Related Articles

City of Hope Selects Michael Friedman As President, CEO

May 16, 2003

The Line Item for Cancer Centers and SPOREs to Remain Flat, Near $598 Million for the 2013 Fiscal Year

April 20, 2012

Funding Opportunities: Career Development Award In Leukemia

July 23, 1999

In Brief: Gene Therapy For ADA Deficiency Moves forward With Stem Cell Treatment In Caif. And At NIH

June 18, 1993

Long-Term Remissions Shown With Chemo Plus Radiation

September 29, 2006

Adjuvant XELOX More Effective Than 5-FU/LV For Stage III Colon Cancer

January 29, 2010